Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn about recent paper he and colleagues co-authored:
“Our new editorial published today in Journal of National Cancer Institute.
Here we discuss how to improve the success rates of phase 3 oncology trials. Open access.”
Title: Success in oncology phase 3 trials: a small P value or patient value
Authors: Laure-Anne Teuwen, Gregory R. Pond, Bishal Gyawali
Read The Full Article at Journal of National Cancer Institute.
More posts featuring Bishal Gyawali.